Home › Funds › Soleus Capital Management, L.P. › INSM

Soleus Capital Management, L.P. position in INSM

INSMED INC · Health Care

Soleus Capital Management, L.P. reported holding 147,000 shares of INSM (INSMED INC) in its Q3 2026 13F filing — a position valued at US$16.8M, representing 0.60% of its reported portfolio and ranking #38 among its reported holdings. Soleus Capital Management, L.P. has disclosed INSM holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)147.00K sh
Reported value held$16.78M
Portfolio Weight0.60%
First reportedQ3 2023
Last changeAdd
Updated2026-11-17

Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR

How Soleus Capital Management, L.P.'s INSM position evolved

Soleus Capital Management, L.P. first disclosed a stake in INSM in Q3 2023 at 218,000 shares (US$5.5M). The position peaked in Q4 2024 at 320,272 shares, worth US$22.1M. Across 13 filings, Soleus Capital Management, L.P. increased the stake 5 time(s), trimmed it 7 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 147,000 shares valued at US$16.8M — an increase of 56,750 shares quarter over quarter.. Notable position changes include a 958% increase in Q4 2024 (shares rose 11% over the following quarter), a 1802% increase in Q4 2025 (shares fell 6% over the following quarter), a 780% increase in Q2 2026 (shares rose 12% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 218.00K $5.50M New
Q4 2023 167.10K $5.18M Reduce
Q1 2024 250.00K $6.78M Add
Q2 2024 102.47K $6.87M Reduce
Q3 2024 30.27K $2.21M Reduce
Q4 2024 320.27K $22.11M Add
Q1 2025 274.27K $20.92M Reduce
Q2 2025 72.77K $7.32M Reduce
Q3 2025 2.55K $367.23K Reduce
Q4 2025 48.50K $8.44M Add
Q1 2026 10.25K $1.68M Reduce
Q2 2026 90.25K $9.62M Add
Q3 2026 147.00K $16.78M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About INSM and 13F data

INSM (INSMED INC) is a Health Care company. 42 other funds we track also report a position in INSM — the largest reported positions include BAKER BROS. ADVISORS LP (US$1.00B), Orbis Allan Gray Ltd (US$768.6M), Artisan Partners Limited Partnership (US$636.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding INSM

All INSM fund holders →

FAQ

How long has Soleus Capital Management, L.P. held INSM?

Soleus Capital Management, L.P. has disclosed INSM holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Soleus Capital Management, L.P.'s current position in INSM?

As of Q3 2026, Soleus Capital Management, L.P. holds 147.00K shares of INSM (INSMED INC), valued at $16.78M, representing 0.60% of its reported portfolio and ranking #38.

Has Soleus Capital Management, L.P. been buying or selling INSM?

In the latest 13F filing (Q3 2026), Soleus Capital Management, L.P. increased its position in INSM. The position peaked in Q4 2024 at 320.27K shares.

Which other funds hold INSM?

Other major institutional holders of INSM include BAKER BROS. ADVISORS LP, Orbis Allan Gray Ltd, Artisan Partners Limited Partnership, among 42 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.